TY - JOUR
T1 - Effect of the COVID-19 pandemic on the pediatric infectious disease landscape
AU - Shmueli, Moshe
AU - Lendner, Idan
AU - Ben-Shimol, Shalom
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - This narrative review aims to present an overview of the COVID-19 pandemic’s effects on the landscape of pediatric infectious diseases. While COVID-19 generally results in mild symptoms and a favorable prognosis in children, the pandemic brought forth significant consequences. These included persistent symptoms among infected children (“long COVID”), a profound transformation in healthcare utilization (notably through the widespread adoption of telemedicine), and the implementation of optimization strategies within healthcare settings. Furthermore, the pandemic resulted in alterations in the circulation patterns of respiratory pathogens, including influenza, RSV, and Streptococcus pneumoniae. The possible reasons for those changes are discussed in this review. COVID-19 effect was not limited to respiratory infectious diseases, as other diseases, including urinary tract and gastrointestinal infections, have displayed decreased transmission rates, likely attributable to heightened hygiene measures and shifts in care-seeking behaviors. Finally, the disruption of routine childhood vaccination programs has resulted in reduced immunization coverage and an upsurge in vaccine hesitancy. In addition, the pandemic was associated with issues of antibiotic misuse and over-prescription. Conclusion: In conclusion, the COVID-19 pandemic has left a profound and multifaceted impact on the landscape of pediatric infectious diseases, ranging from the emergence of “long COVID” in children to significant changes in healthcare delivery, altered circulation patterns of various pathogens, and concerning disruptions in vaccination programs and antibiotic usage. (Table presented.) Graphical Abstract: (Figure presented.)
AB - This narrative review aims to present an overview of the COVID-19 pandemic’s effects on the landscape of pediatric infectious diseases. While COVID-19 generally results in mild symptoms and a favorable prognosis in children, the pandemic brought forth significant consequences. These included persistent symptoms among infected children (“long COVID”), a profound transformation in healthcare utilization (notably through the widespread adoption of telemedicine), and the implementation of optimization strategies within healthcare settings. Furthermore, the pandemic resulted in alterations in the circulation patterns of respiratory pathogens, including influenza, RSV, and Streptococcus pneumoniae. The possible reasons for those changes are discussed in this review. COVID-19 effect was not limited to respiratory infectious diseases, as other diseases, including urinary tract and gastrointestinal infections, have displayed decreased transmission rates, likely attributable to heightened hygiene measures and shifts in care-seeking behaviors. Finally, the disruption of routine childhood vaccination programs has resulted in reduced immunization coverage and an upsurge in vaccine hesitancy. In addition, the pandemic was associated with issues of antibiotic misuse and over-prescription. Conclusion: In conclusion, the COVID-19 pandemic has left a profound and multifaceted impact on the landscape of pediatric infectious diseases, ranging from the emergence of “long COVID” in children to significant changes in healthcare delivery, altered circulation patterns of various pathogens, and concerning disruptions in vaccination programs and antibiotic usage. (Table presented.) Graphical Abstract: (Figure presented.)
KW - Antibiotic stewardship
KW - COVID-19
KW - Healthcare services
KW - Pediatric infectious diseases
KW - SARS‑CoV‑2
KW - Vaccines
UR - http://www.scopus.com/inward/record.url?scp=85171455262&partnerID=8YFLogxK
U2 - 10.1007/s00431-023-05210-x
DO - 10.1007/s00431-023-05210-x
M3 - Review article
C2 - 37726566
AN - SCOPUS:85171455262
SN - 0340-6199
VL - 183
SP - 1001
EP - 1009
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
IS - 3
ER -